AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2013
Jan 10, 2013
29745_dirs_2013-01-10_903fd37b-7b9d-4a3b-9e22-5697743d7db8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2013-01-01
Reporting Person: Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 667 | Direct |
| Common Stock | 780 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee stock option 2/03 (right to buy) | $57.85 | 2013-02-15 | Common Stock (6300) | Direct | |
| Employee stock option 2/04 (right to buy) | $73.11 | 2014-02-14 | Common Stock (5000) | Direct | |
| Employee stock option 2/05 (right to buy) | $55.65 | 2015-02-10 | Common Stock (1314) | Direct | |
| Employee stock option 2/06 (right to buy) | $56.18 | 2016-02-09 | Common Stock (1627) | Direct | |
| Employee stock option 4/03 (right to buy) | $63.67 | 2013-04-26 | Common Stock (7500) | Direct | |
| Restricted Stock Unit | $ | 2016-10-02 | Common Stock (3894) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29